Clinical Trial

Study of MAR002 in Healthy Men

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-23.
Trial Details
NCT Number NCT07195175
Lead Sponsor Marea Therapeutics
Conditions Acromegaly
Enrollment 45 participants
Start Date 2025-08-11
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-12